Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model-Reference-Cited by-同舟云学术

Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model

Published:2018-02-22 Issue:6 Volume:7 Page:e1434465
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Braham Maaike V. J.¹^ORCID,Minnema Monique C.²,Aarts Tineke²³,Sebestyen Zsolt²³,Straetemans Trudy²³,Vyborova Anna²³,Kuball Jurgen²³,Öner F. Cumhur¹,Robin Catherine⁴⁵,Alblas Jacqueline¹

Affiliation:

1. Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands

2. Department of Hematology, University Medical Center Utrecht Cancer Center, Utrecht, The Netherlands

3. Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands

4. Hubrecht Institute-KNAW & University Medical Center Utrecht, Utrecht, The Netherlands

5. Department of Cell Biology, University Medical Center, Utrecht, The Netherlands

Funder

KWF UU

Dutch Arthritis Foundation

Association for International Cancer Research (AICR)

VIDI-ZonMW

University Utrecht Seed Grant

Netherlands Organisation for Health Research and Development (ZonMw)

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1434465

Reference53 articles.

1. The bone marrow niche for haematopoietic stem cells

2. Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?

3. The osteoblastic niche in the context of multiple myeloma

4. Under one roof

5. Myeloma Bone Disease

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications and evolution of 3D cancer-immune cell models;Trends in Biotechnology;2024-07

2. Multi-Niche Human Bone Marrow On-A-Chip for Studying the Interactions of Adoptive CAR-T Cell Therapies with Multiple Myeloma;2024-04-12

3. Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML;Journal for ImmunoTherapy of Cancer;2024-04

4. Utilizing 3D Models to Unravel the Dynamics of Myeloma Plasma Cells’ Escape from the Bone Marrow Microenvironment;Cancers;2024-02-22

5. Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells;Nature Immunology;2023-11-27